arrow_backBack to Catalogue
Sexual Wellness
PT-141
Centrally acting melanocortin agonist that directly enhances sexual desire.
Clinical Profile
- check_circleDirect enhancement of sexual desire (libido)
- check_circleEffective for both men and women
- check_circleWorks independently of the vascular system
- check_circleLong-lasting effects for intimate wellness
biotech
Mechanism of Action
A synthetic peptide that activates MC3R and MC4R receptors in the hypothalamus. Unlike PDE5 inhibitors that target blood flow, PT141 acts directly on the central nervous system to increase sexual desire and arousal.
medication_liquid
Therapeutic Application
Subcutaneous injection administered on an as-needed basis (PRN) before sexual activity.
Ready to include PT-141 in your protocols?
Log in to the prescriber portal to access research monographs, inventory availability, and peer-reviewed clinical studies.